For the first time, EpiVax is hosting two back-to-back seminars in one of our favorite cities: Tokyo, Japan. Join us at the Westin Hotel Tokyo on Thursday, Friday or both! As always, participation is free of cost and will include networking receptions at the close of each seminar.
*Please note: these are in-person seminars with no option for virtual attendance.
Interested in speaking or presenting a poster? Please submit a one-page abstract here.
The 16th annual
Westin Immunogenicity Seminar
The Westin Hotel, Tokyo
Thursday, October 17th
9:00am – 5:00pm
The premier
Computational Vaccinology Symposium
The Westin Hotel, Tokyo
Friday, October 18th
9:00am – 5:00pm
The 16th annual Westin Immunogenicity Seminar will be taking place on Thursday, October 17th. All events (including a key takeaway panel and networking cocktail hour!) will be located at the Westin Tokyo Hotel in Meguro, Tokyo, Japan.
About the Westin Immunogenicity Seminar: The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates, and network with potential collaborators. The purpose of this seminar is to bridge the gap between protein drug development and recent academic research on immunogenicity, deimmunization, and tolerance induction. Confirmed speakers and topics will be announced very soon, register now to save your seat!
“It was a very informative and fruitful seminar on immunogenicity and development of immunotherapeutics for clinical purposes.” -2023 Westin Immunogenicity Seminar attendee
Check out past Westin Immunogenicity Seminars:
2023 Westin Immunogenicity Seminar
2022 Westin Immunogenicity Seminar
2019 Westin Immunogenicity Seminar
While you’re in Tokyo, join us for the Computational Vaccinology Symposium the day after the Westin Immunogenicity Seminar – Friday, October 18th, 2024, at the Westin Hotel. This will be a valuable meeting for industry and academic experts to discuss new data in vaccine design due to recent advances in AI and ML models. More details will be released shortly, register below to be the first to receive updates!
Organizing Commitee:
Yoshimasa Takahashi, PhD Director, National Institute of Infectious Diseases (NIID) Japan
Fumihiko Takeshita, MD PhD Senior Director, Vaccine Business Oversight Dept. Adjuvant Initiative Unit, Daiichi Sankyo Co.
Anne S. De Groot, MD Founder and CSO, EpiVax Inc. (Former CEO)
Ken Ishii, MD PhD Professor, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo